Newborn Care

 

Advanced Technology For When Every Second Counts

Newborn Care

Timely, reliable monitoring is vital when trying to accurately assess a newborn’s oxygenation status at birth and when screening for congenital heart defects. Committed to improving care for this fragile patient population, Masimo has designed sensors and monitoring solutions specifically for newborns that provide clinicians with pertinent physiological data quickly and efficiently – without sacrificing accuracy.

Masimo SET® Measure-through Motion and Low Perfusion™ Pulse Oximetry

Masimo SET® Measure-through Motion and Low Perfusion™ Pulse Oximetry

 

Masimo’s breakthrough Signal Extraction Technology® (SET®) overcomes the limitations of conventional pulse oximetry with the ability to measure through motion and low perfusion. Two separate studies found that Masimo SET® pulse oximeters detected approximately 10 times more true events than other “Next Generation” pulse oximeters studied.1,2

Performance During Motion and Low Perfusion3

Masimo SET® had 3% missed true alarms and 5% false alarms versus 43% and 28%, respectively, using competitor technology.3

Results shown are calculated by combining sensitivity and specificity outcomes of machine-generated and volunteer-generated motion.

In another study comparing the ability of three pulse oximetry technologies to detect hypoxic events, Masimo SET® pulse oximetry demonstrated the highest sensitivity and specificity during induced conditions of motion and low perfusion.3

Solutions for Newborn Resuscitation

Solutions for Newborn Resuscitation

 
Masimo - Newborn Neonatal SpO2 sensors

Newborn Neonatal SpO2 sensors automatically configure Masimo SET® pulse oximeters for the fastest response time and maximum sensitivity settings, allowing clinicians to focus on patient care during newborn resuscitation.

 Velaid SofTouch™ design allows for quick application and repositioning on newborn skin.

Improving CCHD Screening with Masimo SET®

Improving CCHD Screening with Masimo SET®

 

Masimo SET® was the first pulse oximetry technology to receive FDA 510(k) clearance in the labeling to screen newborn patients for critical congenital heart disease (CCHD).5

To date, there have been five published CCHD screening studies, representing a total of 241,239 infants, that used exclusively Masimo SET® pulse oximeters and sensors6-10, two of which (59,876 subjects) were the basis for the CCHD workgroup recommendation for CCHD screening protocols.8,9,11 These studies, all using Masimo SET®, concluded that pulse oximetry, in conjunction with clinical assessment, improved screening sensitivity compared to routine physical exam alone.6-10

Masimo - Rad-97 Radical-7 with Eve Newborn Screening Application

Automating Workflows with Eve™ Newborn Screening Application

Eve combines Masimo SET® measure-through motion pulse oximetry with guided workflows to standardise CCHD screenings. This application also eliminates the need for manual calculations and documentation during CCHD screenings and automates hospital CCHD screening protocols to increase consistency and improve compliance with screening guidelines. 

Masimo SET® Sensors for CCHD Screening

Masimo SET® Sensors for CCHD Screening

 

Multisite Y-I reusable sensors with soft foam wraps – which have been used in multiple prominent CCHD screening studies6-10 - enable quick, comfortable application and removal, without disturbing the patient.


RD SET™ Neo single-patient-use, wrap-around style sensors feature a flat, lightweight cable that lies comfortably on the patient’s hand or foot.

Measurements

Measurements

 
SET®

Masimo SET®

Newborn Care Solutions

 
Masimo - Products - Radical-7

Radical-7®
Masimo - Products - Rad-97 NIBP

Rad-97® with Noninvasive
Blood Pressure
Masimo - Rad-97 with Eve Newborn Screening Application

Eve Newborn Screening Application
Masimo - Products - Root

Root® Platform
Masimo - Products - Specialty - RD SET Newborn

Newborn Sensors
Product shot of Masimo RD SET Adult sensor

RD SET® Sensors
Masimo - Products - LNCS - Y-I Sensor

Reusable Y-I Sensors
Masimo - Products - OEM - MX3

OEM Products

References:

  1. 1.

    Hay WW. J of Perinatol, 2002;22:360-36. 

  2. 2.

    Barker SJ. Anesth Analg. 2002;95(4):967-72.

  3. 3.

    Shah N. et al. J Clin Anesth. 2012 Aug;24(5):385-91.

  4. 4.

    American Academy of Pediatrics (AAP). (2016). Textbook of Neonatal Resuscitation, 7th Ed.

  5. 5.

    Masimo 510(k) Summary - K120657

  6. 6.

    de-Wahl Granelli A et al. Acta Paediatr. 2007 Oct;96(10):1455-9.

  7. 7.

    Meberg A et al. Pediatr. 2008 Jun;152(6):761-5.

  8. 8.

    de-Wahl Granelli A et al. BMJ. 2009 Jan 8;338:a3037. 

  9. 9.

    Ewer AK et al. Lancet. 2011 Aug 27;378(9793):785-94. 

  10. 10.

    Zhao QM et al. Lancet. 2014 Aug 30;384(9945):747-54. 

  11. 11.

    Kemper AR et al. Pediatrics. 2011 Nov;128(5):e1259-67.

RESOURCES

 
Masimo - Brochure, CCHD Screening with Pulse Oximetry Solutions
CCHD Screening with Pulse Oximetry

Brochure

Masimo - Product Information Masimo SET
Masimo SET

Product Information

Masimo - Brochure, RD SET Sensors
RD SET Sensors

Brochure

Masimo - Product Information Product Information
Newborn Sensors

Product Information

Masimo - Rad-97 with Eve Product Information
Eve

Product Information

Masimo - Instructional Guide, CCHD Screening
CCHD Screening

Instructional Guide

Masimo - Product Information - Neonatal & Infant Care Solutions
Neonatal & Infant Care Solutions

Product Information

Eve has obtained CE Marking. Not available in the U.S. or Canada. Rad-97 NIBP is not licensed for sale in Canada.

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.

receive more information email imagereceive more information close image

PLCO-001731/PLM-11168A-0318